Basu, SandipRanade, R.Thapa, P.2016-03-092016-03-092015Nuclear Medicine Communications, 2015. Vol. 36 (8): pp. 766-774http://hdl.handle.net/123456789/126024790 bytestext/htmlenCorrelation and discordancetumour proliferation indexmolecular imaging characteristicstreatment decisionspeptide receptor radionuclide therapyadvanced neuroendocrine tumourCorrelation and discordance of tumour proliferation index and molecular imaging characteristics and their implications for treatment decisions and outcome pertaining to peptide receptor radionuclide therapy in patients with advanced neuroendocrine tumour: developing a personalized modelArticle